2012 Q3 Form 10-Q Financial Statement

#000119312512460371 Filed on November 08, 2012

View on sec.gov

Income Statement

Concept 2012 Q3 2011 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $13.40M $3.433M
YoY Change 290.24% 63.48%
% of Gross Profit
Research & Development $20.91M $6.013M
YoY Change 247.8% -20.88%
% of Gross Profit
Depreciation & Amortization $150.0K $20.00K
YoY Change 650.0% 0.0%
% of Gross Profit
Operating Expenses $34.31M $9.446M
YoY Change 263.22% -3.61%
Operating Profit -$34.31M -$9.446M
YoY Change 263.22%
Interest Expense -$4.570M $3.000K
YoY Change -152433.33% -100.23%
% of Operating Profit
Other Income/Expense, Net -$427.0K -$59.00K
YoY Change 623.73%
Pretax Income -$22.85M $97.11M
YoY Change -123.53% -974.88%
Income Tax $3.573M $767.0K
% Of Pretax Income 0.79%
Net Earnings -$26.43M $96.35M
YoY Change -127.43% -959.53%
Net Earnings / Revenue
Basic Earnings Per Share -$0.18 $0.72
Diluted Earnings Per Share -$0.18 $0.62
COMMON SHARES
Basic Shares Outstanding 149.2M shares 133.2M shares
Diluted Shares Outstanding 149.2M shares 156.0M shares

Balance Sheet

Concept 2012 Q3 2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $215.1M $125.9M
YoY Change 70.85%
Cash & Equivalents $215.1M $125.9M
Short-Term Investments
Other Short-Term Assets $4.110M $2.200M
YoY Change 86.82%
Inventory $8.989M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $228.7M $128.1M
YoY Change 78.57%
LONG-TERM ASSETS
Property, Plant & Equipment $796.0K $100.0K
YoY Change 696.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $15.67M $3.500M
YoY Change 347.77%
Total Long-Term Assets $26.26M $3.600M
YoY Change 629.33%
TOTAL ASSETS
Total Short-Term Assets $228.7M $128.1M
Total Long-Term Assets $26.26M $3.600M
Total Assets $255.0M $131.7M
YoY Change 93.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.70M $3.800M
YoY Change 260.42%
Accrued Expenses $18.80M $2.600M
YoY Change 623.08%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $32.51M $6.400M
YoY Change 408.0%
LONG-TERM LIABILITIES
Long-Term Debt $130.8M $600.0K
YoY Change 21697.17%
Other Long-Term Liabilities $702.0K $155.0M
YoY Change -99.55%
Total Long-Term Liabilities $131.5M $155.6M
YoY Change -15.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $32.51M $6.400M
Total Long-Term Liabilities $131.5M $155.6M
Total Liabilities $255.0M $162.0M
YoY Change 57.38%
SHAREHOLDERS EQUITY
Retained Earnings -$737.1M
YoY Change
Common Stock $737.3M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $217.0K
YoY Change
Treasury Stock Shares 20.08K shares
Shareholders Equity $38.00K -$30.34M
YoY Change
Total Liabilities & Shareholders Equity $255.0M $131.7M
YoY Change 93.62%

Cashflow Statement

Concept 2012 Q3 2011 Q3
OPERATING ACTIVITIES
Net Income -$26.43M $96.35M
YoY Change -127.43% -959.53%
Depreciation, Depletion And Amortization $150.0K $20.00K
YoY Change 650.0% 0.0%
Cash From Operating Activities -$39.42M -$8.270M
YoY Change 376.66% -1.08%
INVESTING ACTIVITIES
Capital Expenditures -$220.0K -$20.00K
YoY Change 1000.0%
Acquisitions
YoY Change
Other Investing Activities -$410.0K -$1.650M
YoY Change -75.15%
Cash From Investing Activities -$630.0K -$1.670M
YoY Change -62.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.900M 4.360M
YoY Change 12.39% 107.62%
NET CHANGE
Cash From Operating Activities -39.42M -8.270M
Cash From Investing Activities -630.0K -1.670M
Cash From Financing Activities 4.900M 4.360M
Net Change In Cash -35.15M -5.580M
YoY Change 529.93% -10.86%
FREE CASH FLOW
Cash From Operating Activities -$39.42M -$8.270M
Capital Expenditures -$220.0K -$20.00K
Free Cash Flow -$39.20M -$8.250M
YoY Change 375.15% -1.32%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q1 amrn Debt Instrument Redemption Price
DebtInstrumentRedemptionPrice
1.00 pure
CY2011Q3 us-gaap Stockholders Equity
StockholdersEquity
-30335000
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
125855000
CY2012Q3 amrn Common Stock Volume Weighted Average Trading Price
CommonStockVolumeWeightedAverageTradingPrice
12.58
CY2012Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
533000
CY2012Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
613087000
CY2012Q3 us-gaap Purchase Obligation
PurchaseObligation
27700000
CY2012Q3 us-gaap Other Assets Current
OtherAssetsCurrent
4110000
CY2012Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
15672000
CY2012Q3 us-gaap Stockholders Equity
StockholdersEquity
38000
CY2012Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
20079 shares
CY2012Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
149901343 shares
CY2012Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10224339 shares
CY2012Q3 us-gaap Liabilities
Liabilities
254960000
CY2012Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
13696000
CY2012Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
702000
CY2012Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
9788000
CY2012Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-737076000
CY2012Q3 us-gaap Assets
Assets
254998000
CY2012Q3 us-gaap Inventory Net
InventoryNet
8989000
CY2012Q3 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
700000
CY2012Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
254998000
CY2012Q3 us-gaap Treasury Stock Value
TreasuryStockValue
217000
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
215110000
CY2012Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
149921422 shares
CY2012Q3 us-gaap Liabilities Current
LiabilitiesCurrent
32512000
CY2012Q3 us-gaap Common Stock Value
CommonStockValue
124244000
CY2012Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2012Q3 us-gaap Assets Current
AssetsCurrent
228742000
CY2012Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
90963000
CY2012Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
1.43
CY2012Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
796000
CY2012Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
130783000
CY2012Q3 amrn Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
18816000
CY2012Q3 amrn Excess Fair Value Over Principal Value
ExcessFairValueOverPrincipalValue
64100000
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
-202367000
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31442000
CY2011Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
533000
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
449393000
CY2011Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1837000
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2241000
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
-5962000
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2011Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
20079 shares
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
135812463 shares
CY2011Q4 us-gaap Liabilities
Liabilities
132341000
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4419000
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
764000
CY2011Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
4734000
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-568459000
CY2011Q4 us-gaap Assets
Assets
126379000
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
126379000
CY2011Q4 us-gaap Treasury Stock Value
TreasuryStockValue
217000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
116602000
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
135832542 shares
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8452000
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
113321000
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2011Q4 us-gaap Assets Current
AssetsCurrent
118972000
CY2011Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
123125000
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
432000
CY2011Q4 amrn Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
4033000
us-gaap Operating Income Loss
OperatingIncomeLoss
-31836000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
932000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
98654000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
30000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6022000
us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
1571000
us-gaap Share Based Compensation
ShareBasedCompensation
6022000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
1543000
us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
1571000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
48000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5073000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27863000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1683000
us-gaap Income Taxes Paid
IncomeTaxesPaid
581000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
98654000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
33000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
94413000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
128377000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5073000
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
1650000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
18661000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-85112000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15651000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
123959000
us-gaap Operating Expenses
OperatingExpenses
31836000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
97000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
1571000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
128377000 shares
us-gaap Revenues
Revenues
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-288000
us-gaap Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
129458000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
31900000 shares
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
57000
us-gaap Net Income Loss
NetIncomeLoss
-87464000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16185000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2352000
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
1000000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-53403000
amrn Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
18661000
amrn Reclassification Of Derivative Liabilities To Additional Paid In Capital
ReclassificationOfDerivativeLiabilitiesToAdditionalPaidInCapital
129458000
amrn Stock Issued During Period Of Stock And Warrants For Services Or Claims
StockIssuedDuringPeriodOfStockAndWarrantsForServicesOrClaims
57000
amrn Increase Decrease In Lease Related Liabilities
IncreaseDecreaseInLeaseRelatedLiabilities
-39000
dei Trading Symbol
TradingSymbol
AMRN
dei Entity Registrant Name
EntityRegistrantName
AMARIN CORP PLC\UK
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2012-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0000897448
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Operating Income Loss
OperatingIncomeLoss
-80794000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
33075000
us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0023 pure
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-411000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13344000
us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
10106000
us-gaap Share Based Compensation
ShareBasedCompensation
13344000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.19
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
2273000
us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
10106000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3107913 shares
us-gaap Depreciation And Amortization
DepreciationAndAmortization
123000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7834000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-78539000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1715000
us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.97 pure
us-gaap Income Taxes Paid
IncomeTaxesPaid
697000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
477000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
98508000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
141947000 shares
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
9365000
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7834000
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
1238000
us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P2Y
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
16526000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-162729000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.19
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39735000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
178762000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1094000
us-gaap Operating Expenses
OperatingExpenses
80794000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-12838000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
10106000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
141947000 shares
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8989000
us-gaap Revenues
Revenues
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
17355000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
20000
us-gaap Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
103885000
us-gaap Interest Paid
InterestPaid
2713000
CY2011Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3200000 shares
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
96345000
CY2011Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3433000
CY2011Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
767000
CY2012Q3 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
97398 shares
CY2011Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9446000
CY2011Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-59000
CY2011Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
CY2011Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
155975000 shares
CY2011Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
22737000 shares
CY2011Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
97112000
CY2011Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
CY2011Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6013000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
38400000 shares
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
24000
us-gaap Net Income Loss
NetIncomeLoss
-168617000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
41059000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
144316000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5888000
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
0
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
108000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-68686000
amrn Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
16526000
amrn Reclassification Of Derivative Liabilities To Additional Paid In Capital
ReclassificationOfDerivativeLiabilitiesToAdditionalPaidInCapital
103885000
amrn Stock Issued During Period Of Stock And Warrants For Services Or Claims
StockIssuedDuringPeriodOfStockAndWarrantsForServicesOrClaims
24000
amrn Increase Decrease In Lease Related Liabilities
IncreaseDecreaseInLeaseRelatedLiabilities
-55000
amrn Adjustments To Additional Paid In Capital Resulting From Conversion Of Convertible Debt Into Equity
AdjustmentsToAdditionalPaidInCapitalResultingFromConversionOfConvertibleDebtIntoEquity
22898000
amrn Proceeds From Stock Options Exercised Gross
ProceedsFromStockOptionsExercisedGross
7800000
amrn Proceeds From Warrant Exercises Gross
ProceedsFromWarrantExercisesGross
16600000
amrn Stock Issued During Period Shares Stock Warrants Exercised
StockIssuedDuringPeriodSharesStockWarrantsExercised
10881276 shares
CY2011Q3 us-gaap Operating Expenses
OperatingExpenses
9446000
CY2011Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
3000
CY2011Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
133238000 shares
CY2011Q3 us-gaap Revenues
Revenues
CY2012Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
622266 shares
CY2012Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1200000
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
149200000 shares
CY2012Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2011Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
106614000
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-34310000
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-427000
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2012Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1600000
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-22853000
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20913000
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
34310000
CY2012Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-4570000
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
149200000 shares
CY2012Q3 us-gaap Revenues
Revenues
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
38400000 shares
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-26426000
CY2012Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13397000
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3573000
CY2012Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
16454000
CY2012Q3 amrn Proceeds From Stock Options Exercised Gross
ProceedsFromStockOptionsExercisedGross
1200000
CY2012Q3 amrn Proceeds From Warrant Exercises Gross
ProceedsFromWarrantExercisesGross
1600000
CY2012Q3 amrn Stock Issued During Period Shares Stock Warrants Exercised
StockIssuedDuringPeriodSharesStockWarrantsExercised
1068654 shares

Files In Submission

Name View Source Status
0001193125-12-460371-index-headers.html Edgar Link pending
0001193125-12-460371-index.html Edgar Link pending
0001193125-12-460371.txt Edgar Link pending
0001193125-12-460371-xbrl.zip Edgar Link pending
amrn-20120930.xml Edgar Link completed
amrn-20120930.xsd Edgar Link pending
amrn-20120930_cal.xml Edgar Link unprocessable
amrn-20120930_def.xml Edgar Link unprocessable
amrn-20120930_lab.xml Edgar Link unprocessable
amrn-20120930_pre.xml Edgar Link unprocessable
d403426d10q.htm Edgar Link pending
d403426dex101.htm Edgar Link pending
d403426dex311.htm Edgar Link pending
d403426dex312.htm Edgar Link pending
d403426dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending